CN Stock MarketDetailed Quotes

Jiangsu Aidea Pharmaceutical Group (688488)

Watchlist
  • 15.97
  • -0.12-0.75%
Market Closed May 20 15:00 CST
6.72BMarket Cap-245.69P/E (TTM)

Jiangsu Aidea Pharmaceutical Group (688488) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
HIV新药(艾诺米替片)254.05M35.33%
药品(尿激酶针剂)216.04M30.04%
低分子量肝素钠及其他82.89M11.53%
番泻叶颗粒75.23M10.46%
乌司他丁粗品38.67M5.38%
HIV新药(艾诺韦林片)30.33M4.22%
其他人源蛋白粗品19.17M2.67%
蜡样芽孢杆菌片1.79M0.25%
Other business994.44K0.14%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacture660.33M91.82%
生物医药原辅料57.84M8.04%
Other business994.44K0.14%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic sales711.13M98.88%
Export sales7.04M0.98%
Other business994.44K0.14%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More